• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群失调与帕金森病中胆汁酸升高有关。

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson's Disease.

作者信息

Li Peipei, Killinger Bryan A, Ensink Elizabeth, Beddows Ian, Yilmaz Ali, Lubben Noah, Lamp Jared, Schilthuis Meghan, Vega Irving E, Woltjer Randy, Pospisilik J Andrew, Brundin Patrik, Brundin Lena, Graham Stewart F, Labrie Viviane

机构信息

Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA.

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.

出版信息

Metabolites. 2021 Jan 4;11(1):29. doi: 10.3390/metabo11010029.

DOI:10.3390/metabo11010029
PMID:33406628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7823437/
Abstract

The gut microbiome can impact brain health and is altered in Parkinson's disease (PD). The vermiform appendix is a lymphoid tissue in the cecum implicated in the storage and regulation of the gut microbiota. We sought to determine whether the appendix microbiome is altered in PD and to analyze the biological consequences of the microbial alterations. We investigated the changes in the functional microbiota in the appendix of PD patients relative to controls ( = 12 PD, 16 C) by metatranscriptomic analysis. We found microbial dysbiosis affecting lipid metabolism, including an upregulation of bacteria responsible for secondary bile acid synthesis. We then quantitatively measure changes in bile acid abundance in PD relative to the controls in the appendix ( = 15 PD, 12 C) and ileum ( = 20 PD, 20 C). Bile acid analysis in the PD appendix reveals an increase in hydrophobic and secondary bile acids, deoxycholic acid (DCA) and lithocholic acid (LCA). Further proteomic and transcriptomic analysis in the appendix and ileum corroborated these findings, highlighting changes in the PD gut that are consistent with a disruption in bile acid control, including alterations in mediators of cholesterol homeostasis and lipid metabolism. Microbially derived toxic bile acids are heightened in PD, which suggests biliary abnormalities may play a role in PD pathogenesis.

摘要

肠道微生物群可影响大脑健康,且在帕金森病(PD)中会发生改变。阑尾是盲肠中的一种淋巴组织,与肠道微生物群的储存和调节有关。我们试图确定PD患者的阑尾微生物群是否发生改变,并分析微生物改变的生物学后果。通过宏转录组分析,我们研究了PD患者(n = 12)相对于对照组(n = 16)阑尾中功能微生物群的变化。我们发现微生物失调影响脂质代谢,包括负责次级胆汁酸合成的细菌上调。然后,我们定量测量了PD患者相对于对照组在阑尾(n = 15 PD,12 C)和回肠(n = 20 PD,20 C)中胆汁酸丰度的变化。PD阑尾中的胆汁酸分析显示疏水性和次级胆汁酸、脱氧胆酸(DCA)和石胆酸(LCA)增加。阑尾和回肠的进一步蛋白质组学和转录组学分析证实了这些发现,突出了PD肠道中与胆汁酸控制破坏一致的变化,包括胆固醇稳态和脂质代谢介质的改变。PD中微生物衍生的有毒胆汁酸升高,这表明胆汁异常可能在PD发病机制中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f6/7823437/fc782f2f718d/metabolites-11-00029-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f6/7823437/c97244777e9c/metabolites-11-00029-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f6/7823437/6259e40bb6ee/metabolites-11-00029-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f6/7823437/1b3cdff3d814/metabolites-11-00029-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f6/7823437/fc782f2f718d/metabolites-11-00029-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f6/7823437/c97244777e9c/metabolites-11-00029-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f6/7823437/6259e40bb6ee/metabolites-11-00029-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f6/7823437/1b3cdff3d814/metabolites-11-00029-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f6/7823437/fc782f2f718d/metabolites-11-00029-g004.jpg

相似文献

1
Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson's Disease.肠道微生物群失调与帕金森病中胆汁酸升高有关。
Metabolites. 2021 Jan 4;11(1):29. doi: 10.3390/metabo11010029.
2
Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.帕金森病患者循环系统中肠道微生物代谢产物的改变。
J Parkinsons Dis. 2022;12(4):1219-1230. doi: 10.3233/JPD-223179.
3
Increasing the Hindgut Carbohydrate/Protein Ratio by Cecal Infusion of Corn Starch or Casein Hydrolysate Drives Gut Microbiota-Related Bile Acid Metabolism To Stimulate Colonic Barrier Function.通过盲肠灌注玉米淀粉或酪蛋白水解物提高后肠碳水化合物/蛋白质比例可驱动肠道微生物群相关的胆汁酸代谢,从而刺激结肠屏障功能。
mSystems. 2020 Jun 2;5(3):e00176-20. doi: 10.1128/mSystems.00176-20.
4
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.帕金森病患者的肠道微生物群改变和炎症细胞因子反应。
J Neuroinflammation. 2019 Jun 27;16(1):129. doi: 10.1186/s12974-019-1528-y.
5
Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis.肠道微生物群失调与婴儿胆汁淤积症中胆汁酸代谢改变有关。
mSystems. 2019 Dec 17;4(6):e00463-19. doi: 10.1128/mSystems.00463-19.
6
Interactions of bile acids and the gut microbiota: learning from the differences in infection between children and adults.胆汁酸与肠道微生物群的相互作用:从儿童和成人感染的差异中学习。
Physiol Genomics. 2019 Jun 1;51(6):218-223. doi: 10.1152/physiolgenomics.00034.2019. Epub 2019 May 10.
7
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.肠道微生物失调与帕金森病中的微生物代谢产物。
Ageing Res Rev. 2018 Aug;45:53-61. doi: 10.1016/j.arr.2018.04.004. Epub 2018 Apr 26.
8
Bunge and Salisb. modulate gut microbiome and bile acid metabolism to inhibit colon cancer progression.邦奇和索尔兹伯里调节肠道微生物群和胆汁酸代谢以抑制结肠癌进展。
Front Microbiol. 2024 Jun 17;15:1395634. doi: 10.3389/fmicb.2024.1395634. eCollection 2024.
9
Bile Acids as Modulators of α-Synuclein Aggregation: Implications for Parkinson's Therapy.胆酸作为α-突触核蛋白聚集的调节剂:对帕金森病治疗的启示。
ACS Chem Neurosci. 2024 Nov 6;15(21):4055-4065. doi: 10.1021/acschemneuro.4c00459. Epub 2024 Oct 15.
10
The Role of the Gut Microbiota in Bile Acid Metabolism.肠道微生物群在胆汁酸代谢中的作用。
Ann Hepatol. 2017 Nov;16(Suppl. 1: s3-105.):s15-s20. doi: 10.5604/01.3001.0010.5494.

引用本文的文献

1
Trends in intestinal aging: From underlying mechanisms to therapeutic strategies.肠道衰老的趋势:从潜在机制到治疗策略。
Acta Pharm Sin B. 2025 Jul;15(7):3372-3403. doi: 10.1016/j.apsb.2025.05.011. Epub 2025 May 22.
2
Exploring the role of gut microbiota in Parkinson's disease: insights from fecal microbiota transplantation.探索肠道微生物群在帕金森病中的作用:来自粪便微生物群移植的见解
Front Neurosci. 2025 Jun 13;19:1574512. doi: 10.3389/fnins.2025.1574512. eCollection 2025.
3
The Determination of Trimethylamine N-Oxide and Organic Acids Connected with Gut Microbiota in the Urine of Parkinson's Disease Patients: A Pilot Study.

本文引用的文献

1
Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease.色氨酸代谢物与帕金森病的症状和黑质病理有关。
Mov Disord. 2020 Nov;35(11):2028-2037. doi: 10.1002/mds.28202. Epub 2020 Jul 25.
2
The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota.Elobixibat 对慢性便秘的益处与粪便脱氧胆酸有关,而与改变的微生物群无关。
Aliment Pharmacol Ther. 2020 Sep;52(5):821-828. doi: 10.1111/apt.15950. Epub 2020 Jul 20.
3
Appendectomy, Tonsillectomy and Parkinson's Disease Risk: A Swedish Register-Based Study.
帕金森病患者尿液中与肠道微生物群相关的氧化三甲胺和有机酸的测定:一项初步研究。
Int J Mol Sci. 2025 May 10;26(10):4575. doi: 10.3390/ijms26104575.
4
Short-chain fatty acids mediate enteric and central nervous system homeostasis in Parkinson's disease: Innovative therapies and their translation.短链脂肪酸介导帕金森病中的肠道和中枢神经系统稳态:创新疗法及其转化。
Neural Regen Res. 2026 Mar 1;21(3):938-956. doi: 10.4103/NRR.NRR-D-24-01265. Epub 2025 Apr 29.
5
Metabolomics in Parkinson's Disease and Correlation with Disease State.帕金森病中的代谢组学及其与疾病状态的相关性
Metabolites. 2025 Mar 18;15(3):208. doi: 10.3390/metabo15030208.
6
The Inflammatory Mechanism of Parkinson's Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut-Brain Axis.帕金森病的炎症机制:肠道微生物群代谢产物通过肠-脑轴影响疾病发展。
Brain Sci. 2025 Feb 6;15(2):159. doi: 10.3390/brainsci15020159.
7
Comparative Analysis of γ-Cyclodextrin, Perilla Oil, and Their Inclusion Complexes on Liver Injury and Dyslipidemia Associated with Elevated Gastrointestinal 12-Hydroxylated Bile Acid Levels.γ-环糊精、紫苏油及其包合物对与胃肠道12-羟基化胆汁酸水平升高相关的肝损伤和血脂异常的比较分析
Molecules. 2025 Jan 13;30(2):281. doi: 10.3390/molecules30020281.
8
Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome-Wide Association Study.肠道微生物代谢产物与帕金森病的未来风险:一项全代谢组关联研究
Mov Disord. 2025 Mar;40(3):556-560. doi: 10.1002/mds.30054. Epub 2024 Nov 12.
9
Gut microbiota and Parkinson's disease.肠道微生物群与帕金森病
Chin Med J (Engl). 2025 Feb 5;138(3):289-297. doi: 10.1097/CM9.0000000000003318. Epub 2024 Nov 6.
10
α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice.α-突触核蛋白过表达与微生物群影响小鼠肠道和大脑代谢组。
NPJ Parkinsons Dis. 2024 Oct 30;10(1):208. doi: 10.1038/s41531-024-00816-w.
阑尾切除术、扁桃体切除术与帕金森病风险:一项基于瑞典登记处的研究
Front Neurol. 2020 Jun 5;11:510. doi: 10.3389/fneur.2020.00510. eCollection 2020.
4
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.肠道微生物组与帕金森病风险和前驱标志物的特征。
Ann Neurol. 2020 Aug;88(2):320-331. doi: 10.1002/ana.25788. Epub 2020 Jun 15.
5
Incidental Prophylactic Appendectomy Is Associated with a Profound Microbial Dysbiosis in the Long-Term.偶然预防性阑尾切除术长期与严重的微生物群落失调相关。
Microorganisms. 2020 Apr 23;8(4):609. doi: 10.3390/microorganisms8040609.
6
Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease-A Pilot Study.帕金森病患者口服熊去氧胆酸的药代动力学、安全性和耐受性——一项初步研究
J Clin Pharmacol. 2020 Jun;60(6):744-750. doi: 10.1002/jcph.1575. Epub 2020 Feb 12.
7
Tryptophan Metabolism by Gut Microbiome and Gut-Brain-Axis: An Analysis.肠道微生物群与肠-脑轴对色氨酸的代谢:一项分析
Front Neurosci. 2019 Dec 18;13:1365. doi: 10.3389/fnins.2019.01365. eCollection 2019.
8
Microbial bile acid metabolites modulate gut RORγ regulatory T cell homeostasis.微生物胆汁酸代谢物调节肠道 RORγ 调节性 T 细胞稳态。
Nature. 2020 Jan;577(7790):410-415. doi: 10.1038/s41586-019-1865-0. Epub 2019 Dec 25.
9
Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota.帕金森病及相关药物对粪便细菌微生物群组成的影响。
NPJ Parkinsons Dis. 2019 Nov 29;5:28. doi: 10.1038/s41531-019-0100-x. eCollection 2019.
10
Bile acid metabolites control T17 and T cell differentiation.胆汁酸代谢物控制 T17 和 T 细胞分化。
Nature. 2019 Dec;576(7785):143-148. doi: 10.1038/s41586-019-1785-z. Epub 2019 Nov 27.